Nutra Pharma Corp (NPHC) stock
NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $806.69KP/E –Yield –
Nutra Pharma gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Nutra Pharma's gross profit for the twelve months ending Jun 30, 2026 was $104.27K, down 62.7% year over year. For fiscal 2025 it was $196.63K, down 20.5% from the year before. Over ten years it grew -1.4% a year on average. The highest annual figure on record is $815.44K in fiscal 2010.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $196.63K | -20.5% |
| FY2024 | Dec 31, 2024 | $247.32K | -37.6% |
| FY2023 | Dec 31, 2023 | $396.46K | +59.2% |
| FY2022 | Dec 31, 2022 | $249.02K | +2841.1% |
| FY2021 | Dec 31, 2021 | $8.47K | -43.2% |
| FY2020 | Dec 31, 2020 | $14.92K | -57.0% |
| FY2019 | Dec 31, 2019 | $34.72K | +146.9% |
| FY2018 | Dec 31, 2018 | $14.06K | -85.1% |
| FY2017 | Dec 31, 2017 | $94.08K | – |
| FY2016 | Dec 31, 2016 | -$54.65K | -124.2% |
| FY2015 | Dec 31, 2015 | $225.50K | -53.0% |
| FY2014 | Dec 31, 2014 | $480.21K | +654.2% |
| FY2013 | Dec 31, 2013 | $63.67K | +14.4% |
| FY2012 | Dec 31, 2012 | $55.64K | – |
| FY2011 | Dec 31, 2011 | -$719.99K | -188.3% |
| FY2010 | Dec 31, 2010 | $815.44K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $32.63K | -48.6% |
| Q1 FY2026 | Mar 31, 2026 | $18.98K | -67.9% |
| Q4 FY2025 | Dec 31, 2025 | -$11.91K | -113.8% |
| Q3 FY2025 | Sep 30, 2025 | $64.58K | -8.7% |
| Q2 FY2025 | Jun 30, 2025 | $63.43K | +15.6% |
| Q1 FY2025 | Mar 31, 2025 | $59.13K | +68.0% |
| Q4 FY2024 | Dec 31, 2024 | $86.59K | -7.6% |
| Q3 FY2024 | Sep 30, 2024 | $70.69K | -38.5% |
| Q2 FY2024 | Jun 30, 2024 | $54.85K | -35.2% |
| Q1 FY2024 | Mar 31, 2024 | $35.20K | -65.9% |
| Q4 FY2023 | Dec 31, 2023 | $93.74K | -34.7% |
| Q3 FY2023 | Sep 30, 2023 | $114.98K | +68.7% |
| Q2 FY2023 | Jun 30, 2023 | $84.64K | +186.1% |
| Q1 FY2023 | Mar 31, 2023 | $103.10K | +1223.1% |
| Q4 FY2022 | Dec 31, 2022 | $143.50K | – |
| Q3 FY2022 | Sep 30, 2022 | $68.15K | +608.3% |
| Q2 FY2022 | Jun 30, 2022 | $29.58K | +37.9% |
| Q1 FY2022 | Mar 31, 2022 | $7.79K | -52.5% |
| Q4 FY2021 | Dec 31, 2021 | -$39.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $9.62K | -6.3% |
| Q2 FY2021 | Jun 30, 2021 | $21.45K | +739.6% |
| Q1 FY2021 | Mar 31, 2021 | $16.39K | +38.5% |
| Q4 FY2020 | Dec 31, 2020 | -$9.74K | – |
| Q3 FY2020 | Sep 30, 2020 | $10.27K | -71.1% |
| Q2 FY2020 | Jun 30, 2020 | $2.56K | -60.3% |
| Q1 FY2020 | Mar 31, 2020 | $11.84K | -53.9% |
| Q4 FY2019 | Dec 31, 2019 | -$32.89K | – |
| Q3 FY2019 | Sep 30, 2019 | $35.47K | +440.9% |
| Q2 FY2019 | Jun 30, 2019 | $6.44K | -49.7% |
| Q1 FY2019 | Mar 31, 2019 | $25.70K | -3.5% |
| Q4 FY2018 | Dec 31, 2018 | -$31.92K | -210.1% |
| Q3 FY2018 | Sep 30, 2018 | $6.56K | -28.6% |
| Q2 FY2018 | Jun 30, 2018 | $12.81K | -35.8% |
| Q1 FY2018 | Mar 31, 2018 | $26.62K | -11.0% |
| Q4 FY2017 | Dec 31, 2017 | $28.99K | – |
| Q1 FY2017 | Mar 31, 2017 | $9.19K | – |
| Q2 FY2016 | Jun 30, 2016 | $19.96K | – |
| Q1 FY2016 | Mar 31, 2016 | $29.91K | – |
See a number that looks wrong?